RxDoctor Payments Data

Alexander Ryan, DO

Internal Medicine · Lincoln, NENPI 1912319344

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Shionogi Inc at 59.1% of the total. 2025 is the largest year on record at $3,030, more than ten times the $25 reported in 2019. Among internal medicine clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,077in general payments, 2019–2025

Across 10 payments — averaging $507.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shionogi Inc$3K
  • Modernatx, Inc.$2K
  • Pfizer$55
  • Sanofi$30
  • Novo Nordisk$14
$2,148,256in research payments, 2019–2025

Across 870 payments — averaging $2469.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$697K
  • Modernatx, Inc.$419K
  • Sanofi US Services Inc.$281K
  • Vertex$265K
  • Janssen Research & Development, LLC$238K
  • Novavax Inc$169K
  • plus $80K from 4 others

What the payments were for

  • Consulting fees$3,00059%
  • Travel & lodging$1,72334%
  • Food & beverage$3547%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Shionogi Inc1$3,000
Modernatx, Inc.4$1,978
Pfizer3$55
Sanofi1$30
Novo Nordisk1$14

How this compares

$5,077 in reported general payments places this provider in the 90th percentile of 570 internal medicine providers in Nebraska.

See all internal medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$88,229
Medicare patients
569
Services billed
594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →